「Interleukin (IL)-17A is a potent prognostic factor associated with intratumoral neutrophil infiltration and C-X-C chemokine motif ligand 1 in triple-negative breast cancer」の関連論文
-
Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma
-
Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor α
-
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer
-
S-1-Propenylcysteine promotes IL-10-induced M2c macrophage polarization through prolonged activation of IL-10R/STAT3 signaling
-
S-1-Propenylcysteine promotes IL-10-induced M2c macrophage polarization through prolonged activation of IL-10R/STAT3 signaling
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-κB Pathway and Epithelial-Mesenchymal Transition
-
IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α
-
The Interaction between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer
-
SEPSIS INDUCES DEREGULATION OF IL-13 PRODUCTION AND PD-1 EXPRESSION IN LUNG GROUP 2 INNATE LYMPHOID CELLS
-
Biological and clinical significance of the YKL-40/osteopontin–integrin β4–p70S6K axis induced by macrophages in early oesophageal squamous cell carcinoma
-
Involvement of Transcription Factor 21 in the Pathogenesis of Fibrosis in Endometriosis
-
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment
-
Development of macrophage-targeted therapy using peptide/protein-loaded extracellular vesicles
-
Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice
-
Oncolytic herpes simplex virus HF10 (canerpaturev, C-REV) promotes accumulation of CD8^+PD-1^- tumor-infiltrating T cells in PD-L1–enriched tumor microenvironment
-
Cutaneous Liver X Receptor Activation Prevents the Formation of Imiquimod-Induced Psoriatic Dermatitis
-
Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression
-
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis
-
CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
-
CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s
-
A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
-
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
-
The mechanistic role of fatty acid binding protein 7 (FABP7) in tumor proliferation
-
FE65 in breast cancer: its clinicopathological and biological significance
-
Targeting tumor-intrinsic Nuclear Factor-kappa B signaling pathway for the discovery of anti-metastatic drug candidates from natural recourses
-
Inactivation of the PD-1-dependent immunoregulation in mice exacerbates contact hypersensitivity resembling immune-related adverse events
-
The role of vagus nerve stimulation through acetylcholine receptor during atherosclerosis progression
-
Escin inhibits angiogenesis by suppressing interleukin-8 and vascular endothelial growth factor production by blocking nuclear factor-κB activation in pancreatic cancer cell lines
-
Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells
-
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling.
-
Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria
-
Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria
-
Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL- induced caspase activation
-
Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL- induced caspase activation
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Differential Roles of Dendritic Cells in Expanding CD4 T Cells in Sepsis
-
Salivary cytokine panel indicative of non-small cell lung cancer
-
Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
-
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
-
Tenascin C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
-
Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients